- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Bioventus Faces Competitive Landscape in Medical Devices
Bioventus, a North Carolina-based medical device company, competes with 27 other public firms in the surgical and medical instruments industry.
Mar. 8, 2026 at 7:08am
Got story updates? Submit your updates here. ›
Bioventus (NASDAQ:BVS) is a medical device company focused on developing and commercializing treatments that engage the body's natural healing process. The company operates in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, competing with 27 other public firms. While Bioventus has higher revenue than its competitors, it has lower earnings per share and trades at a higher price-to-earnings ratio, indicating it may be more expensive than other companies in the industry.
Why it matters
The analysis of Bioventus and its competitors provides insight into the competitive landscape of the medical devices industry. Factors like profitability, valuation, institutional ownership, and volatility can impact a company's long-term growth and success, making this comparison relevant for investors and industry observers.
The details
Bioventus' portfolio includes pain treatments, surgical solutions, and restorative therapies for the orthopedic market. The company serves physicians across various specialties in clinics, ambulatory surgical centers, and hospitals. While Bioventus has higher revenue than its peers, it lags in earnings per share and trades at a higher valuation. Analysts believe Bioventus' competitors have more favorable growth aspects. Bioventus also has stronger institutional ownership and insider ownership compared to the industry average, which can signal confidence in the company's prospects.
- Bioventus was founded in 2011 and is headquartered in Durham, North Carolina.
The players
Bioventus Inc.
A medical device company that focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally.
Surgical, Medical, And Dental Instruments And Supplies industry
The industry that Bioventus operates in, which includes 27 other public companies.
The takeaway
Bioventus faces a competitive landscape in the medical devices industry, with 27 other public companies operating in the same space. While the company has higher revenue, it lags in profitability and trades at a premium valuation compared to its peers. Investors and industry observers will want to closely monitor Bioventus' ability to differentiate itself and drive long-term growth in this crowded market.



